Rock Springs Capital Management »

Indivior shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Indivior shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Indivior

Tip: Access up to 7 years of quarterly data

All positions including Indivior held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 105k 35.88

More positions owned by Rock Springs Capital Management

Eli Lilly & Co. (LLY)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
EXACT Sciences Corporation (EXAS)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Structure Therapeutics Sponsored Ads (GPCR)
Intuitive Surgical Com New (ISRG)
Cidara Therapeutics Com New (CDTX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Irhythm Technologies (IRTC)
Kymera Therapeutics (KYMR)

View all positions for Rock Springs Capital Management

Top funds holding Indivior

Oaktree Capital Management
BlackRock
Hanna Zanoni
Vanguard Group
Two Seas Capital
State Street Corporation
Deerfield Management Company
Goldman Sachs Group
Acadian Asset Management
Geode Capital Management
Citadel Advisors
Divisadero Street Capital Management
Mangrove Partners
Newtyn Management
Millennium Management

View all funds holding Indivior